/ Received USFDA Approval For Itraconazole Capsules – Alkem Labs ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Thursday, 15 June 2017

On Thursday a multinational pharma company Alkem Labs which were  received the approval from the U.S FDA approval for the itraconazole capsules.It is used for the fungal infection.

These capsules which were used for the treatment of the  fungal infection in the lungs. IT is also used for the for the fingernails and toenails etc.

On Thursday The stock of the company on NSE the trading session which was traded at Rs.1,886 per share and high at Rs19 per share. For the period of 1 year the stock delivered at 36%.

It is engaged in the manufacture, development and sale of the pharmaceutical and neutraceutical products.

or Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔